Management of Persistent Fever Despite Antipyretics

Understanding Fever Persistence in Critical Illness

The median time to defervescence in critically ill patients with hematologic malignancies is 5 days after starting appropriate antibiotics, while patients with solid tumors typically defervesce within 2 days, indicating that persistent fever alone in an otherwise stable patient is rarely an indication to alter the antibiotic regimen and does not predict mortality 3

Obtain chest radiograph immediately for any ICU patient with new fever, as pneumonia is the most common infection causing fever in critically ill patients, according to the American Thoracic Society 1, 2, 4
For post-surgical patients, perform CT imaging of the operative area if fever persists beyond several days and no alternative cause is identified, as recommended by the Society of Critical Care Medicine 1, 4
Blood cultures should be obtained before antibiotic administration when fever occurs with elevated neutrophils, as this combination suggests bacteremia, based on guidelines from the Infectious Diseases Society of America 5
For persistent fever beyond 4-6 days, consider imaging of chest and upper abdomen to exclude fungal infection or abscesses, particularly if C-reactive protein is rising, as suggested by the European Society of Clinical Microbiology and Infectious Diseases 6

Antipyretic therapy does not improve mortality or clinical outcomes in critically ill patients, with a meta-analysis of 13 RCTs showing no improvement in 28-day mortality, according to the American College of Critical Care Medicine 1, 2, 4
Avoid routine use of antipyretics for the specific purpose of reducing temperature in critically ill patients, as recommended by the Society of Critical Care Medicine 1, 2, 4
Use antipyretics only for symptomatic relief when patients or families value comfort over temperature reduction, based on guidelines from the American Academy of Critical Care Medicine 1, 2, 4

Neutropenic fever requires immediate empirical antibiotics regardless of antipyretic response, according to the National Comprehensive Cancer Network 6, 7
Hemodynamic instability or clinical deterioration with fever warrants broadening antibiotic coverage and seeking infectious disease consultation, not escalating antipyretics, as recommended by the Society of Critical Care Medicine 6, 3

For stable patients with persistent fever, continue initial antibiotics if patient remains clinically stable at 48 hours, even if febrile, based on guidelines from the Infectious Diseases Society of America 3
Do not empirically add vancomycin for persistent fever alone, as studies show no benefit in time-to-defervescence, according to the American College of Critical Care Medicine 3

Antibiotics can be discontinued when neutrophil count ≥0.5 × 10⁹/L, patient asymptomatic, afebrile for 48 hours, and blood cultures negative, as recommended by the European Society of Clinical Microbiology and Infectious Diseases 6, 7

For patients with COVID-19 symptoms, paracetamol is preferred over NSAIDs until more evidence is available, and antipyretics should not be used solely to reduce body temperature, according to the World Health Organization 8